A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07435311 · COMPLETED
Trial details
- NCT number
- NCT07435311
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-15
- Primary completion
- 2024-07-17
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.